Epigenetic therapy in urologic cancers: an update on clinical trials
Pedro Castelo‐Branco(Champalimaud Foundation)
Cited by 39
Related Papers
Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations
|Nature Genetics|2014|654
Subgroup-Specific Prognostic Implications of <i>TP53</i> Mutation in Medulloblastoma
|Journal of Clinical Oncology|2013|488
Assessing cognitive decline in the aging brain: lessons from rodent and human studies
|npj Aging|2023|160
Roadmap of DNA methylation in breast cancer identifies novel prognostic biomarkers
|BMC Cancer|2019|147
THOR is a targetable epigenetic biomarker with clinical implications in breast cancer
|Clinical Epigenetics|2022|15